康泰醫學(300869.SZ):簽署國有建設用地使用權出讓合同
格隆匯9月24日丨康泰醫學(300869.SZ)公佈,近日,公司與秦皇島市自然資源和規劃局經濟技術開發區分局簽署《國有建設用地使用權出讓合同》,取得坐落於開發區西區,編號K2021-17地塊39263.97平方米的國有建設用地使用權,並於2021年9月24日支付全部款項人民幣1654.59萬元,其中,出讓金1590.19萬元,印花税、契税64.40 萬元。
根據公司與秦皇島經濟技術開發區管理委員會簽訂的投資協議,此次購買的土地使用權將作為康泰醫學產業園項目用地,屬於項目規劃進展事項。項目建成後,將進一步優化公司產業佈局,鞏固提升產品在細分領域的行業地位,抓住智能製造發展機遇,搶佔戰略制高點,增強公司全產業鏈的技術創新和自主可控能力,提升公司盈利能力和核心競爭力,促進公司的長期持續發展。符合公司整體發展戰略及全體股東利益,為公司創造新的利潤增長點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.